CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contrast-enhanced intraoperative ultrasound (CE-IOUS) plays an increasingly important role in the surgical therapy planning of primary liver lesions as well as liver metastases.

The present study was designed to evaluate the significance of CE-IOUS by specificity and sensitivity and particularly the impact it exerts on the surgical strategy.

A secondary aim was assessing the outcome relevance of surgeries influenced by CE-IOUS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)

NCT00243633

Focal Liver Lesions Liver Cancer Liver Cirrhosis

COMPLETED NA

Role of CEUS as a Secondary Diagnostic Modality

NCT04494022

Hepatocellular Carcinoma

UNKNOWN NA

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

NCT06876805

Focal Liver Lesion

RECRUITING

Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer

NCT03026452

Liver Cancer

UNKNOWN PHASE1/PHASE2

Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging

NCT04682886

Focal Liver Lesions Contrast-enhanced Ultrasound

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CE-IOUS has been used during hepatobiliary surgery for almost 25 years. During this time, it has proven to be an excellent diagnostic tool for detecting and characterising previously unknown lesions.

It is still unclear to what extent the findings of this imaging modality impacts the strategy of such operations.

The currently planned study is intended to evaluate the impact of contrast-enhanced intraoperative ultrasound on the surgical procedure in hepatic surgery.

For this purpose, patient data of the time period between 2017 and 2019 was prospectively analysed.

Another aim of the study was to measure the outcome relevance of CE-IOUS. This assessment was carried out by comparing an intervention cohort with a control cohort. The control cohort consisted of patients that were operated due similar liver lesions as the intervention cohort however did not receive CE-IOUS during the operation. Aspects like the recurrence free time and overall survival rate of the two cohorts were compared together with the patients' characteristics of the groups themselves.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Neoplasms Liver/Hepatobiliary Cancer Colorectal Cancer Metastatic Metastases Surgery Ultrasound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention cohort

Patients that were operated due to liver neoplasms with use of CE-IOUS

CE-IOUS

Intervention Type PROCEDURE

Use of contrast-enhanced intraoperative ultrasound during liver surgery

Control cohort

Patients that were operated due to liver neoplasms without use of CE-IOUS

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CE-IOUS

Use of contrast-enhanced intraoperative ultrasound during liver surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Operations during study period from 01/2017 until 12/2019
* Elective liver surgery in the department of surgery at the University Hospital Regensburg
* Liver resections due to primary hepatic tumours (benign, malignant) or hepatic metastases
* Liver surgery with intraoperative use of CE-IOUS